Relief

Studies suggest that there is no protection against SARS-CoV-2 infections from recent exposure to HCoVs

Study shows lower antibody cross-reactivity after infection with the B.1.1.7 SARS-CoV-2 difference

Results of a phase 2 trial of the Novavax reconstituted SARS-CoV-2 nanoparticle vaccine

Genetic mutation associated with COVID-19 production

Pfizer SARS-CoV-2 vaccine effective from day 11 after 1d vaccine

How SARS-CoV-2 proteins affect biologic activity

Study showing long-term neuropsychological effects after SARS-CoV-2 infection

Measuring SARS-CoV-2 viral pressure in hospitalized patients

Spinal cord-free energy study of SARS-CoV-2 anxiety modifications

Comparative analysis of SARS-CoV-2 antivirals leads to a possible new treatment for COVID-19